Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

10.38
BATS BZX Real-Time Price
As of 10:37am ET
 +0.04 / +0.39%
Today’s Change
6.78
Today|||52-Week Range
11.34
+29.59%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$12.5B

Company Description

Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and supportive care, infectious diseases and human immunodeficiency viruses, and colds and coughs. The firm operates through following geographical segments: North America, Europe and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Contact Information

Teva Pharmaceutical Industries Ltd.
124 Dvora HaNevi'a Street
Tel Aviv Tel Aviv 6944020
P:(723) 914-8213
Investor Relations:
(723) 926-7516

Employees

Shareholders

Other institutional32.28%
Mutual fund holders15.56%
Individual stakeholders0.14%

Top Executives

Kåre SchultzPresident, Chief Executive Officer & Director
Eric DrapéExecutive Vice President-Global Operations
Eli KalifChief Financial Officer & Executive Vice President
Eric A. HughesChief Medical Officer, Executive VP-Global R&D
Lori A. QueisserSenior Vice President & Global Compliance Officer